A novel interleukin 13 (IL-13) antagonist that blocks the biological activity of human IL-13 in immune and nonimmune cells. |
| |
Authors: | Y Oshima R K Puri |
| |
Institution: | Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA. |
| |
Abstract: | |
| |
Keywords: | |
|
|